Login to Your Account

Amarin to Launch Vascepa Alone with $100M Debt Financing

By Catherine Shaffer
Staff Writer

Friday, December 7, 2012

Amarin Corp. plc CEO Joe Zakrzewski insisted that it would be "a mistake" to assume the company's decision to launch Vascepa on its own through the use of a $100 million debt instrument meant that it had abandoned its search for a partner for the fish oil-based product it is developing for the cardiovascular disease market.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription